Lv4
670 积分 2023-09-15 加入
Knockdown of CTRP6 inhibits adipogenesis via lipogenic marker genes and Erk1/2 signalling pathway
28天前
已完结
Development of a Highly Sensitive C1qc-Targeting Aptamer and its Application in a Modified Antibody-Aptamer Sandwich Biosensor for C1qc Biomarker Detection
28天前
已完结
PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets
1个月前
已完结
Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)
1个月前
已完结
Mitigation of non-alcoholic steatohepatitis via recombinant Orosomucoid 2, an acute phase protein modulating the Erk1/2-PPARγ-Cd36 pathway
1个月前
已完结
CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis
2个月前
已完结
CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis
2个月前
已完结
Isoflavones as a smart curer for non-alcoholic fatty liver disease and pathological adiposity via ChREBP and Wnt signaling
3个月前
已完结
Wnt5b stimulates adipogenesis by activating PPARγ, and inhibiting the β-catenin dependent Wnt signaling pathway together with Wnt5a
3个月前
已关闭
Current Progress and Challenges in the Development of Pharmacotherapy for Metabolic Dysfunction‐Associated Steatohepatitis
4个月前
已完结
皖公网安备34019202002308
